Results 221 to 230 of about 303,324 (255)

Detection of circulating tumor cells and microemboli in the blood of lung adenocarcinoma in situ patients case reports. [PDF]

Discov Oncol
Huang Y, Zhang H, Fan D, Wang Z, Qin X, Sun X, Zhu L.   +6 more
europepmc   +1 more source

Breast cancer stem cells and circulating tumor cells: Dual drivers of progression and relapse. [PDF]

World J Stem Cells
Azizi Z, Er Urganci B, Acikbas I.
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow-up of high-grade serous ovarian cancer. [PDF]

Mol Oncol
Salmon C, Neves RPL, Stoecklein NH, Liffers ST, Siveke J, Kuhlmann JD, Wimberger P, Buderath P, Kimmig R, Kasimir-Bauer S.   +9 more
europepmc   +1 more source

Diagnostic and Prognostic Utility of Cell-Surface Vimentin Positive Circulating Tumor Cells in Breast Cancer Using an Automated Negative Selection Platform. [PDF]

Diseases
Yeh MH, Lin MC, Tsai HJ, Liu YC, Wang TM, Hung WS, Lin CP, Liang CH, Tseng CJ.   +8 more
europepmc   +1 more source

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer. [PDF]

Diagnostics (Basel)
Eisses B, Angus L, Kuip EJM, Menke-van der Houven van Oordt CW, van der Vegt B, Glaudemans AWJM, Brouwers AH, Oprea-Lager DE, Oyen WJG, Emmering J, Sieuwerts AM, Jager A, Kraan J, Martens JWM, de Vries EGE, Sleijfer S, Schröder CP, IMPACT-MBC Consortium.   +17 more
europepmc   +1 more source

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Blood
Fokkema C, Bertamini L, de Jong MME, Tahri S, Hofste Op Bruinink D, Kellermayer Z, Papazian N, den Hollander C, Vermeulen MPW, Stoetman ECG, van Beek G, Hoogenboezem R, van der Velden VHJ, Hulin C, Perrot A, Moreau P, Rowe M, Vieyra D, Carson R, van Duin M, Sanders MA, Broijl A, Sonneveld P, Cupedo T.   +23 more
europepmc   +1 more source

Liquid Biopsy for Cutaneous Melanoma: Opportunities and Challenges in Detecting and Characterizing Circulating Tumor Cells. [PDF]

J Derm Oncol
Wang W, Rickett R, Teertam S, Gunasekaran S, Setaluri V.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Circulating Tumor Cells and Circulating Tumor DNA

Annual Review of Medicine, 2012
Solid tumors derived from epithelial tissues (carcinomas) are responsible for 90% of all new cancers in Europe, and the main four tumor entities are breast, prostate, lung, and colon cancer. Present tumor staging is mainly based on local tumor extension, metastatic lymph node involvement, and evidence of overt distant metastasis obtained by imaging ...
Catherine, Alix-Panabières, Heidi, Schwarzenbach, Klaus, Pantel   +2 more
openaire   +2 more sources

Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers

Urologic Clinics of North America, 2023
Liquid biopsies such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have great potential to serve as prognostic and predictive biomarkers in urologic cancers. The possibility of using liquid biopsies for real-time noninvasive and dynamic monitoring of response to therapy has been an active area of investigation.
Ikenna, Madueke, Richard J, Lee, David T, Miyamoto   +2 more
openaire   +2 more sources